Published in Invest Ophthalmol Vis Sci on February 17, 2010
Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol (2012) 2.24
Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer. Mol Med (2011) 1.41
Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol Med (2011) 1.34
Histone deacetylases as targets for treatment of multiple diseases. Clin Sci (Lond) (2013) 1.16
Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway : scriptaid protects against TBI via AKT. Neurotherapeutics (2013) 1.04
Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity. Invest Ophthalmol Vis Sci (2012) 0.96
Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart. Life Sci (2012) 0.92
Review: Epigenetic mechanisms in ocular disease. Mol Vis (2013) 0.91
Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina. Invest Ophthalmol Vis Sci (2011) 0.90
Diosmin protects rat retina from ischemia/reperfusion injury. J Ocul Pharmacol Ther (2012) 0.86
Inhibition of HDAC2 protects the retina from ischemic injury. Invest Ophthalmol Vis Sci (2013) 0.86
Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration. Exp Eye Res (2014) 0.85
Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2α. Mol Vis (2012) 0.85
P2X₇ receptor activation may be involved in neuronal loss in the retinal ganglion cell layer after acute elevation of intraocular pressure in rats. Mol Vis (2013) 0.84
Histone deacetylase 3 (HDAC3) plays an important role in retinal ganglion cell death after acute optic nerve injury. Mol Neurodegener (2014) 0.84
Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction. Am J Physiol Heart Circ Physiol (2015) 0.82
Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension. Invest Ophthalmol Vis Sci (2014) 0.81
The role of epigenetics in age-related macular degeneration. Eye (Lond) (2014) 0.81
Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism. Int J Physiol Pathophysiol Pharmacol (2010) 0.80
Histone Deacetylases Exert Class-Specific Roles in Conditioning the Brain and Heart Against Acute Ischemic Injury. Front Neurol (2015) 0.78
Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and Perspectives. J Ophthalmol (2015) 0.78
Ischemia/Reperfusion. Compr Physiol (2016) 0.78
EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia. Mol Ther (2014) 0.77
Attenuation of choroidal neovascularization by histone deacetylase inhibitor. PLoS One (2015) 0.77
Ischemic preconditioning, retinal neuroprotection and histone deacetylase activities. Exp Eye Res (2016) 0.77
A role for epigenetic changes in the development of retinal neurodegenerative conditions. J Ocul Biol Dis Infor (2012) 0.75
Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression. New Front Ophthalmol (2016) 0.75
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer (2006) 10.73
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell (2002) 7.10
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol (2008) 6.90
Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity (1999) 5.50
Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science (2005) 5.31
Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature (2000) 4.93
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci (2003) 3.67
Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res (2004) 3.08
Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol (2005) 3.05
Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet (2005) 2.68
Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A (2001) 2.56
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem (2004) 2.43
Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol (2002) 2.15
TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (2001) 2.04
Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond) (2005) 1.90
Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol (2006) 1.67
Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem Pharmacol (2004) 1.63
Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2005) 1.46
Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci (2005) 1.40
Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther (2005) 1.37
Long-term tolerance to retinal ischemia by repetitive hypoxic preconditioning: role of HIF-1alpha and heme oxygenase-1. Invest Ophthalmol Vis Sci (2007) 1.35
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthritis Cartilage (2008) 1.35
Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors. J Neurosci (2006) 1.19
Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis. Brain Res (2008) 1.16
Histone acetylation and the cell-cycle in cancer. Front Biosci (2001) 1.16
Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci (2005) 1.13
Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. J Cell Physiol (2006) 1.12
Histone deacetylases as transducers and targets of nuclear signaling. J Cell Biochem (2008) 1.11
Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci (2008) 1.09
Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci (2009) 1.09
Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection. BMC Genomics (2008) 1.08
Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci (2003) 1.07
Purification of astrocytes from adult human optic nerve heads by immunopanning. Brain Res Brain Res Protoc (2003) 1.05
Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27. Curr Med Res Opin (2004) 1.02
Requirement of histone deacetylase activity for the expression of critical photoreceptor genes. BMC Dev Biol (2007) 1.02
Ischemic preconditioning alters the pattern of gene expression changes in response to full retinal ischemia. Mol Vis (2007) 1.00
Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas. J Neurochem (2008) 0.99
Involvement of erythropoietin in retinal ischemic preconditioning. Anesthesiology (2009) 0.97
Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. Invest Ophthalmol Vis Sci (2007) 0.97
Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina. Invest Ophthalmol Vis Sci (2006) 0.97
p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-D-aspartate. Mol Vis (2002) 0.95
Retinal ischemic preconditioning in the rat: requirement for adenosine and repetitive induction. Invest Ophthalmol Vis Sci (1999) 0.93
Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes. Growth Factors (2009) 0.93
Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9. Invest Ophthalmol Vis Sci (2005) 0.85
The effect of ischemic preconditioning on light-induced photoreceptor injury. Invest Ophthalmol Vis Sci (2003) 0.82
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med (2008) 9.05
Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis (2007) 2.31
Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet (2002) 2.09
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother (2006) 1.99
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation (2006) 1.94
Antibiotic resistance: a survey of physician perceptions. Arch Intern Med (2002) 1.91
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. J Am Coll Cardiol (2011) 1.74
Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. J Infect (2010) 1.67
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Microtubule-dependent distribution of mRNA in adult cardiocytes. Am J Physiol Heart Circ Physiol (2008) 1.55
Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl (2006) 1.49
Fungal infections in solid organ transplantation. Med Mycol (2007) 1.39
Cardiac-specific expression and hypertrophic upregulation of the feline Na(+)-Ca(2+) exchanger gene H1-promoter in a transgenic mouse model. Circ Res (2002) 1.35
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation (2010) 1.35
Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis (2009) 1.34
Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant (2011) 1.32
Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J Clin Invest (2007) 1.32
Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant (2003) 1.27
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis (2012) 1.25
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23
Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother (2004) 1.21
Clinical evaluation of multiplex real-time PCR panels for rapid detection of respiratory viral infections. J Med Virol (2011) 1.16
mTOR in growth and protection of hypertrophying myocardium. Cardiovasc Hematol Agents Med Chem (2009) 1.15
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14
Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol (2006) 1.12
Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biol (2010) 1.11
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis (2002) 1.11
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10
Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09
Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol (2004) 1.09
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen. Antimicrob Agents Chemother (2006) 1.06
Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation (2005) 1.05
Cryptococcus neoformans Infection in Patients With Cirrhosis, Including Liver Transplant Candidates. Medicine (Baltimore) (2004) 1.04
Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02
Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med (2007) 1.00
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant (2007) 0.98
LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant (2003) 0.96
Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation. J Ocul Pharmacol Ther (2003) 0.96
STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMX. Int J Biol Sci (2008) 0.96
Regulation of protein synthesis by eIF4E phosphorylation in adult cardiocytes: the consequence of secondary structure in the 5'-untranslated region of mRNA. Biochem J (2004) 0.96
A direct test of the hypothesis that increased microtubule network density contributes to contractile dysfunction of the hypertrophied heart. Am J Physiol Heart Circ Physiol (2008) 0.95
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis (2008) 0.95
Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. J Clin Virol (2008) 0.95
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis (2010) 0.94
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol (2012) 0.94
Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo. Stem Cells Dev (2010) 0.93
Phenotypic consequences of beta1-tubulin expression and MAP4 decoration of microtubules in adult cardiocytes. Am J Physiol Heart Circ Physiol (2003) 0.93
beta-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes. J Mol Cell Cardiol (2009) 0.92
RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum. Am J Physiol Regul Integr Comp Physiol (2003) 0.92
Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation (2008) 0.92
The role of p38 in the regulation of Na+-Ca2+ exchanger expression in adult cardiomyocytes. J Mol Cell Cardiol (2005) 0.92
Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant (2002) 0.91
Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulation. J Biol Chem (2006) 0.90
The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant (2009) 0.90
Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes. FASEB J (2009) 0.90
Role of sodium-calcium exchanger (Ncx1) in embryonic heart development: a transgenic rescue? Ann N Y Acad Sci (2002) 0.89
Evidence for multiple P2Y receptors in trabecular meshwork cells. J Pharmacol Exp Ther (2004) 0.88
Late-onset invasive aspergillosis in organ transplant recipients in the current era. Med Mycol (2006) 0.87
Hypertrophic stimulation increases beta-actin dynamics in adult feline cardiomyocytes. PLoS One (2010) 0.87
Differential regulation of the cardiac sodium calcium exchanger promoter in adult and neonatal cardiomyocytes by Nkx2.5 and serum response factor. J Mol Cell Cardiol (2002) 0.87
Inhibition of HDAC2 protects the retina from ischemic injury. Invest Ophthalmol Vis Sci (2013) 0.86
Site-specific microtubule-associated protein 4 dephosphorylation causes microtubule network densification in pressure overload cardiac hypertrophy. J Biol Chem (2010) 0.86
DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells. J Cell Biochem (2008) 0.86
Cardiac expression of ms1/STARS, a novel gene involved in cardiac development and disease, is regulated by GATA4. Mol Cell Biol (2012) 0.85
C-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction. J Pharmacol Exp Ther (2012) 0.85
Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients. Antimicrob Agents Chemother (2006) 0.85
Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo. Invest Ophthalmol Vis Sci (2014) 0.84
Pharmacoeconomic assessment of therapy for invasive aspergillosis. Mycoses (2013) 0.84
Basis for MAP4 dephosphorylation-related microtubule network densification in pressure overload cardiac hypertrophy. J Biol Chem (2010) 0.84
Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms. Biochemistry (2006) 0.84
Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Invest Ophthalmol Vis Sci (2013) 0.83
Kinin modulation of conventional outflow facility in the bovine eye. J Ocul Pharmacol Ther (2006) 0.83
Fungi and molds following lung transplantation. Semin Respir Crit Care Med (2010) 0.83
Chronic administration of KB-R7943 induces up-regulation of cardiac NCX1. J Biol Chem (2009) 0.82
Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation (2014) 0.82
Assessment of infection risks prior to lung transplantation. Curr Opin Infect Dis (2010) 0.82
Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes. Exp Eye Res (2008) 0.81
Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection. Transpl Immunol (2006) 0.80
Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort study. Leuk Lymphoma (2012) 0.80
Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort study. Transplantation (2011) 0.79
Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis. J Infect (2013) 0.79
Mold infections in lung transplant recipients. Semin Respir Crit Care Med (2013) 0.78
Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failure. Adv Exp Med Biol (2013) 0.78
Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation (2010) 0.78
Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect (2006) 0.78
Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis. Curr Infect Dis Rep (2013) 0.77
Community-acquired respiratory viral infections in lung transplant recipients. Curr Opin Infect Dis (2013) 0.77
Delta-opioid receptors attenuate TNF-α-induced MMP-2 secretion from human ONH astrocytes. Invest Ophthalmol Vis Sci (2013) 0.77
Role of MAP kinases in the Na+/Ca2+ exchanger gene expression in feline adult cardiocytes. Ann N Y Acad Sci (2002) 0.77
Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann Transplant (2010) 0.76
Peri-operative novel 2009 H1N1 influenza virus infection successfully treated with oseltamivir and zanamivir in a lung transplant recipient. J Heart Lung Transplant (2010) 0.76
Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant (2008) 0.76
Fungal infections in lung transplant recipients. Curr Opin Pulm Med (2008) 0.76
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis. Transplantation (2009) 0.76
Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients. Transplantation (2017) 0.76
NCX1 phosphorylation dilemma: a little closer to resolution. Focus on "Full-length cardiac Na+/Ca2+ exchanger 1 protein is not phosphorylated by protein kinase A". Am J Physiol Cell Physiol (2011) 0.75
Nanowires and Electrical Stimulation Synergistically Improve Functions of hiPSC Cardiac Spheroids. Nano Lett (2016) 0.75